Complete Genomics Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2012 to a ratio of 3.58, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the third quarter 2012. Average receivable collection period, for the Complete Genomics Inc in Sep 30 2012 quarter, has decreased to 102 days, compared to 116 days, in the Jun 30 2012 quarter.

If we take a look into Healthcare sector 271 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2012 from 0 to 2892.

What is Receivable Turnover Ratio?
What is Complete Genomics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GNOM Receivables Turnover Ratio	(Sep 30 2012) III. Quarter	(Jun 30 2012) II. Quarter	(Mar 31 2012) I. Quarter	(Dec 31 2011) IV. Quarter	(Sep 30 2011) III. Quarter
Y / Y Receivable Change	9.05 %	-1.71 %	20.96 %	-	-
Y / Y Revenue Change	74.19 %	48.22 %	-42.81 %	-40.66 %	283.56 %
Receivable Turnover Ratio (TTM)	3.58	3.14	2.66	3.27	4.91
GNOM's Total Ranking	# 2892	# 0	# 0	# 0	#
Accounts Receivable average collection period days	102	116	137	111	74
Seq. Receivable Change	-24.53 %	19.4 %	-7.85 %	31.31 %	-31.97 %
Seq. Revenue Change	-16.3 %	122.44 %	58.28 %	-40.89 %	-28.78 %

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 19
Healthcare Sector	# 272
Overall Market	# 2892

Receivable Turnover Ratio Statistics
High	Average	Low
0.21	0.19	0.16
(Sep 30 2012)		(Jun 30 2012)

GNOM Company Profile • Back to GNOM Efficiency Comparisons • Compare GNOM Receivables Turnover Ratio to its Competitors

Financial Statements
Complete Genomics Inc's Accounts Receivable	$ 5 Millions	Visit GNOM's Balance sheet
Complete Genomics Inc's Sales TTM	$ 22 Millions	Visit GNOM's Income Statement
Sources of GNOM's Revenues		Visit GNOM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GNOM's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GNOM's Growth Rates	GNOM's Roa	GNOM's Inventory Turnover Ratio	GNOM's Dividend Comparisons
GNOM's Profitability Ratios	GNOM's Roi	GNOM's Asset Turnover Ratio	GNOM's Dividend Growth
GNOM's Valuation Ratios	GNOM's Roe	GNOM's Financial Strength Ratios	GNOM's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2012, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2012	Receivable at quarter ending Sep 30 2012
Rockwell Medical inc	11.39	$ 48.739 Millions	$ 4.278 Millions
Genmark Diagnostics Inc	11.38	$ 13.061 Millions	$ 1.148 Millions
Bio techne Corp	11.36	$ 311.989 Millions	$ 27.475 Millions
American Caresource Holdings, Inc.	11.20	$ 38.827 Millions	$ 3.467 Millions
Ligand Pharmaceuticals Incorporated	11.08	$ 30.690 Millions	$ 2.769 Millions
Genomic Health Inc	10.92	$ 228.143 Millions	$ 20.885 Millions
International Stem Cell Corporation	10.84	$ 4.381 Millions	$ 0.404 Millions
Apyx Medical Corp	10.75	$ 27.002 Millions	$ 2.511 Millions
Surmodics Inc	10.67	$ 52.382 Millions	$ 4.910 Millions
Antares Pharma Inc	10.43	$ 22.501 Millions	$ 2.156 Millions
Gadsden Properties, Inc.	10.29	$ 194.609 Millions	$ 18.906 Millions
Option Care Health Inc	10.07	$ 1,903.684 Millions	$ 189.048 Millions
Spero Therapeutics Inc	10.00	$ 16.028 Millions	$ 1.603 Millions
Nektar Therapeutics	9.78	$ 75.827 Millions	$ 7.753 Millions
Encision Inc	9.58	$ 12.513 Millions	$ 1.307 Millions
Sanuwave Health Inc	9.52	$ 0.853 Millions	$ 0.090 Millions
Quidelortho Corp	9.50	$ 140.207 Millions	$ 14.752 Millions
Vertex Pharmaceuticals Inc	9.49	$ 1,756.388 Millions	$ 185.152 Millions
Sonoma Pharmaceuticals Inc	9.45	$ 14.718 Millions	$ 1.557 Millions
Allied Healthcare Products inc	9.39	$ 42.030 Millions	$ 4.476 Millions
Myriad Genetics Inc	9.36	$ 518.990 Millions	$ 55.423 Millions
Reflect Scientific Inc	9.28	$ 1.413 Millions	$ 0.152 Millions
Henry Schein Inc	9.21	$ 8,871.677 Millions	$ 963.385 Millions
Enliven Therapeutics Inc	9.08	$ 0.240 Millions	$ 0.026 Millions
Cadence Pharmaceuticals Inc	9.04	$ 38.899 Millions	$ 4.305 Millions
Ensign Group Inc	9.01	$ 806.280 Millions	$ 89.503 Millions
United Therapeutics Corporation	9.00	$ 867.437 Millions	$ 96.341 Millions
Icu Medical Inc	8.90	$ 310.667 Millions	$ 34.894 Millions
Koru Medical Systems Inc	8.77	$ 7.230 Millions	$ 0.824 Millions
Astrotech Corp	8.76	$ 27.426 Millions	$ 3.131 Millions

Date modified: 2026-09-08T15:07:16+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.